期刊文献+

一种独特的新抗癫痫药——左乙拉西坦 被引量:3

A unique new type drug of anti-epileptic drug--Levetiracetam
下载PDF
导出
摘要 左乙拉西坦(Levetiracetam,LEV)是最新上市的新一代抗癫痫药,其结构式及机制不同于其他抗癫痫药,具有较为理想的药代动力学。临床研究表明对难治性癫痫的有效率为30%~50%,对各类型癫痫均有较好的疗效。单药治疗亦有效。成人推荐剂量为1 000~3 000mg/d。常见的不良反应有头痛、嗜睡、乏力、眩晕、情绪不稳、人格障碍等,出现率在25%以下。对认知障碍影响的出现率<6% 。不良反应均为轻~中度。
作者 王薇薇 吴逊
出处 《临床药物治疗杂志》 2004年第6期52-56,51,共6页 Clinical Medication Journal
  • 相关文献

同被引文献40

  • 1田国红,赵忠新.左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J].中国新药与临床杂志,2006,25(10):782-786. 被引量:43
  • 2Abou-Khalil B. Levetiracetam in the treatment of epilepsy[J]. Neuropsychiatr Dis Treat,2008, 4:507-523.
  • 3欧盟批准左乙拉西坦单一治疗癫痫患者部分性发作.世界临床药物,2006,27:579-579.
  • 4Brodie MJ, Perucca E, Ryvlin P, et al. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy [J]. Neurology, 2007,68:402-408.
  • 5Alsaadi TM, Thieman C, Zusman EE. Levetiracetam monotherapy for adults with localization-related epilepsy[J]. Epilepsy Behav, 2002,3:471-474.
  • 6Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000rag/day in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy[J]. Epilepsia,2000,41 : 1276-1283.
  • 7Alsaadi TM, Shatzel A, Marquez AV, et al. Clinical experience of levetriracetam monotherapy for adults with epilepsy: 1-year follow-up studyIJJ. Seizure,2005,14:139-142.
  • 8Verrotti A, Cerminara C, Domizio S,et al. Levetiracetam in absence epilepsy[J]. Dev Med Child Neurol,2008, 50:850-853.
  • 9Coppola G, Franzoni E, Verrotti A, et al. Levetiracetam or oxcarbazepine as monotberapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes(BECTS): an openlabel, parallel group trial[J]. Brain Dev, 2007,29:281-284.
  • 10Di Bonaventura C, Fattouch J, Mari F, et al. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes[J]. Epilaptic Disord, 2005,7:231-235.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部